Can a smartphone app ease the burden of multiple myeloma?

NCT ID NCT06073353

Ongoing Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile app called THRIVE-M designed to help people with multiple myeloma cope with symptoms, emotions, and relationships. About 120 patients will either use the app or receive usual care. Researchers will measure whether the app improves quality of life, reduces distress, and lessens fatigue after 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: THRIVE-M mobile application (psychosocial support program)
What this could lead to: If it works, this app could offer a simple, at-home way to help multiple myeloma patients feel better emotionally and physically during treatment.
What could go wrong: This is a small, early-stage trial testing a behavioral intervention, not a drug. The app may not provide significant benefits over usual care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

Massachusetts General Hospital

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.